Walgreens Connected Care® Oncology Program receives U.S. patent

Proprietary technology enables and helps guide specialty pharmacist interactions with patients prescribed oral oncology medications

DEERFIELD, Ill., 2018-Jan-30 — /EPR Retail News/ — Walgreens has received a U.S. patent for new proprietary technology that its Walgreens community specialty pharmacists and AllianceRx Walgreens Prime’s specialty pharmacists will use to facilitate communication with and counseling of patients prescribed oral oncology medicines. Through Walgreens Connected Care® Oncology, an evidence-based, patient-centered process focused on driving medication adherence and improving patient outcomes, this newly patented technology helps guide interactions with patients, helping them stay on their treatment and manage any possible side effects.

Historically, chemotherapy and other cancer medicines have been administered under the direct supervision of a medical professional in an outpatient clinic or in-patient hospital. However, more recently medical science has created oral cancer medicines called oncolytics that patients can take from the comfort of their home. While oncolytics offer convenience, they are still powerful medicines designed to treat cancer in accordance with complex treatment plans that are critical to patient outcomes.

“As more and more cancer patients are self-administering oral oncolytic medications without medical supervision, there is no way for providers to know if the patient is taking the medication as prescribed or what side effects they may be experiencing,” said Rick Miller, senior director, specialty clinical services at AllianceRx Walgreens Prime and one of the patent developers. “This is where our interaction guiding system, coupled with pharmacy experts, becomes extremely valuable as it drives communication with our patients, and allows our pharmacists to gather important information about their treatment.”

The patented technology arms Walgreens and AllianceRx Walgreens Prime specialty pharmacy teams with a set of questions and informational scripts to guide conversations with Connected Care Oncology patients. Branching logic within the technology adapts the set of questions and informational scripts in real time. Each patient interaction is customized to focus on patient specific variables – including prescribed medication, adverse events and adherence – and provides the proper support to the patient based on their current situation. Walgreens and AllianceRx Walgreens Prime captures the data and provides it to the patient’s oncologist for informational purposes and continuity of care.

“Oral oncology is a growing area of cancer care, one that requires appropriate patient management and support to maximize the best potential outcomes and make our patients lives easier,” said Matt Farber, senior director, patient care and advocacy at Walgreens. “The complexity of managing patients on oral oncolytics led us to develop this technology, that when coupled with pharmacists’ clinical expertise, helps us to deliver the best care to our patients as they go through their cancer treatment. We are honored to be awarded this patent as it demonstrates our continued commitment to patient care and innovation.”

About AllianceRx Walgreens Prime

AllianceRx Walgreens Prime delivers maintenance medicines and specialty medicines through its mail service and central specialty pharmacies. Formed in 2017 through a strategic alliance between Walgreens, one of the nation’s largest chain drug stores, and Prime Therapeutics, a leading pharmacy benefit manager (PBM), the company offers tools and resources to help patients improve medication adherence, 24/7 pharmacy support for exceptional care. The company is headquartered in Orlando, Fla. and its pharmacies are accredited by several national pharmacy accreditation services. Visit www.alliancerxwp.com for more information.

About Walgreens

Walgreens (walgreens.com), a provider of trusted care in communities since 1901, is included in the Retail Pharmacy USA Division of Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the first global pharmacy-led, health and wellbeing enterprise. Approximately 8 million customers interact with Walgreens in stores and online each day, using the most convenient, multichannel access to consumer goods and services and trusted, cost-effective pharmacy, health and wellness services and advice. Walgreens operates 8,100 drugstores with a presence in all 50 states, the District of Columbia, Puerto Rico and the U.S. Virgin Islands, along with its omnichannel business, Walgreens.com. Approximately 400 Walgreens stores offer Healthcare Clinic or other provider retail clinic services.

Contact(s):
Walgreens
Scott Goldberg
(847) 315-7649
http://news.walgreens.com
@WalgreensNews
facebook.com/Walgreens

Source: Walgreens

New initiative launched to drive awareness of the importance of mammography

CHICAGO, 2017-Jun-06 — /EPR Retail News/ — Susan G. Komen Chicago has set a big, bold goal of helping reduce breast cancer deaths by 50% in the U.S. by 2026. In an effort to reach this momentous goal, one initiative the organization is embarking on is the Rewards For Mammograms program, a collaboration with Walgreens and major healthcare providers in the Chicagoland area. As part of Rewards For Mammograms, Komen Chicago, along with its collaborators, have a program goal of encouraging at least 100,000 Chicagoland women to get mammograms by October 31, 2017.

Women who get a mammogram by October 31, 2017 from a participating healthcare facility will have the opportunity to be rewarded with 1,000 Walgreens Balance® Rewards points.* Walgreens will also donate $1, up to $30,000, to Susan G. Komen Chicago, for each valid program voucher redeemed in-store through October 31.**

“Susan G. Komen Chicago is excited to launch this ambitious initiative as we continue to drive awareness of the importance of mammography,” says Bonnie Gordon, Executive Director of Susan G. Komen Chicago. “With Rewards For Mammograms, we want Chicagoland women to know getting a mammogram is easy, but more importantly, it is vital as early detection is key in the fight to reduce breast cancer deaths in Chicago and the U.S.”

Today through October 31, participants can go to any participating healthcare facility, including all Chicagoland Presence Health Hospitals, to have a mammogram. From there, getting a mammogram and being rewarded for it is as easy as 1, 2, and 3 for program participants:

  1. Make an appointment with any participating Chicagoland healthcare facility
  2. Complete an appointment
    • Upon completion of the appointment, participants will receive a Walgreens Balance® Rewards voucher from their participating healthcare provider
  3. Redeem completed voucher at any Chicagoland Walgreens
    • Participant must present a completed voucher by October 31, 2017 to  receive 1,000 Walgreens Balance®Rewards points at checkout‡

“We’re proud to be a part of the Rewards For Mammograms program, and to have the opportunity to collaborate with Komen Chicago as it focuses on an aggressive goal to reduce breast cancer deaths in the community,” says Matt Farber, Walgreens senior director of oncology disease state. “Walgreens has long been committed to the cancer community, helping patients get access to medications, connect with valuable educational resources and manage prescription therapies – supporting them throughout their journey from screening and diagnosis to treatment and into survivorship.”

Congresswoman Robin Kelly (D-IL 2nd District), a supporter of the program, adds, “Mammograms and early detection are our greatest weapons in the fight against breast cancer. This remarkable program will help save lives by making mammograms accessible to all, especially those who have been historically medically underserved.”

For additional information or questions regarding the Rewards For Mammograms program, please visit www.KomenChicago.org/Walgreens or call Susan G. Komen Chicago’s headquarters at (773) 444 – 0061.

About Komen Chicago: Susan G. Komen’s promise is to save lives and end breast cancer forever by energizing science to find cures, ensuring quality care for all and empowering people with knowledge. Komen Chicago donates 75 percent of net funds raised to community grants in the Chicago area and dedicates 25 percent to global research. For more information on Komen Chicago, please visit www.komenchicago.org.

*Offer valid 6/4/17 thru 10/31/17 with Walgreens Balance® Rewards card and completed redemption voucher in participating stores in Illinois, Indiana and Wisconsin. Must be a Balance® Rewards member to receive points. Limit one redemption voucher per card member. Points good on next purchase. Void if copied or transferred. Exclusions and restrictions apply to redeeming points. Complete Balance Rewards details at Walgreens.com/Balance.

** Between 6/4/17 and 10/31/17 for every valid program voucher presented and redeemed in store, Walgreens will give $1, up to $30,000, to Susan G. Komen Chicago.

‡Participants must either be existing Walgreens Balance® Rewards members or sign up onsite at a Walgreens store to be eligible to receive the 1,000 points.

Contact:

email media@walgreens.com
847-315-2921

Source: Walgreens